Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
E
EAPI
vs
D
DAX Index
Over the past 12 months, EAPI has underperformed DAX Index, delivering a return of -77% compared to DAX Index's +4% growth.
Stocks Performance
EAPI vs DAX Index
Performance Gap
EAPI vs DAX Index
Performance By Year
EAPI vs DAX Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Euroapi SAS
Glance View
Euroapi SAS makes active pharmaceutical ingredients, or APIs, which are the main chemical substances used in medicines. It also helps drug makers develop and manufacture certain complex molecules. In simple terms, Euroapi sits in the middle of the pharmaceutical supply chain: it turns chemistry into the building blocks that other companies use to make finished drugs. Its customers are mainly pharmaceutical companies, generic drug makers, and some healthcare groups that need a reliable source of regulated ingredients. Euroapi sells these ingredients and related manufacturing services under long-term supply relationships and project work tied to specific molecules. The company’s money comes from producing APIs, customizing them for customer needs, and supporting development and manufacturing programs. What makes Euroapi distinct is its focus on large-scale pharmaceutical chemistry rather than branded medicines. It works in a highly regulated industry where quality, traceability, and consistent supply matter as much as the chemical product itself. That makes Euroapi less like a consumer drug company and more like a specialized industrial supplier to the medicines market.